This course provides an in-depth understanding of the neurobiology of addictions and the assessment, diagnosis, and medical management of substance use disorders. Participants will learn about the prevalence and consequences of cannabis, stimulant, opioid, and alcohol use disorders. The course will also cover the management of withdrawal from opioids, alcohol, and benzodiazepines.
- Give an overview of the neurobiology of addiction and how it affects the neuroplastic changes in the brain
- Screen patients with substance use disorders and provide appropriate treatment
- Recognize the prevalence and consequences of cannabis use disorder and its impact on patients' medical and social well-being
- Identify and manage patients with stimulant use disorder and discuss DSM-5 criteria diagnosis
- Describe the value of using medication-assisted treatment to help patients with opioid use problems
- Identify high-risk factors of patients who are candidates for naloxone
- Discuss developmental components of managing patients with alcohol use disorder and commonly used medication-assisted withdrawal techniques
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and American Osteopathic Academy of Addiction Medicine. The AOA is accredited by the ACCME to provide continuing medical education for physicians. The AOA designates this activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Osteopathic Academy of Addiction Medicine (AOAAM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOAAM designates this activity for 8.0 AOA Category 1-A CME Credits.
Course Expires: June 16, 2026